
Pomerantz Law Firm Investigates Potential Securities Claims: A Call for Affected Investors
Pomerantz LLP Investigates Potential Securities Claims Against Zentalis Pharmaceuticals New York, NY – Pomerantz LLP, a leading securities law firm, is investigating potential securities claims on behalf of investors of Zentalis Pharmaceuticals, Inc. (“Zentalis” or the “Company”) (NASDAQ: ZNTL). Background Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery and development of small…